US Biolab

US Biolab operates as a specialized services provider in the life sciences research sector, functioning as a biobank and biospecimen-focused CRO. The company leverages a worldwide network of clinical sites to offer custom sample collection and maintains a biorepository of over 500,000 human biospecimens, including tissues, serum, plasma, and nucleic acids. Its service portfolio extends to tissue microarray construction, histology, and molecular pathology (IHC, FISH, ISH), positioning it as an enabling partner for drug and diagnostic development. With a long operational history since 1987, it serves a stable but competitive niche market supporting preclinical and translational research.

Integrated global biospecimen collection network and biorepository with over 500,000 human samples, coupled with in-house capabilities for custom tissue microarray construction and a full suite of molecular pathology services (IHC, FISH, ISH, microdissection, nucleic acid extraction).

US Biolab competes in a fragmented market including large, full-service contract research organizations (CROs) with biospecimen divisions, academic and hospital-affiliated biobanks, and other commercial specimen providers like BioIVT, Discovery Life Sciences, and Indivumed. Its differentiation lies in its integrated model of custom collection, a large proprietary repository, and in-house pathology services, offering a one-stop shop for tissue-based research needs.